Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Breast Neoplasms 558Carcinoma, Non-Small-Cell Lung 517Prostatic Neoplasms 335Colorectal Neoplasms 273Neoplasms 268Multiple Myeloma 267Leukemia, Myeloid, Acute 224Squamous Cell Carcinoma of Head and Neck 217Lung Neoplasms 210Neoplasm Metastasis 205Carcinoma, Hepatocellular 197Melanoma 175Triple Negative Breast Neoplasms 173Pancreatic Neoplasms 171Recurrence 152Ovarian Neoplasms 152Lymphoma 141Glioblastoma 134Brain Neoplasms 133Sarcoma 130Carcinoma, Renal Cell 129Stomach Neoplasms 125Lymphoma, Large B-Cell, Diffuse 125Leukemia, Lymphocytic, Chronic, B-Cell 125Head and Neck Neoplasms 125Rectal Neoplasms 109Precursor Cell Lymphoblastic Leukemia-Lymphoma 109Myelodysplastic Syndromes 103Uterine Cervical Neoplasms 100Urinary Bladder Neoplasms 100

Interventions

3-(3'-adamantan-1-yl-4'-methoxybiphenyl-4-yl)-2-propenoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Differentiated Thyroid Carcinoma × 1 year × Clear all
NCT06359847 2025-08-24

Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer

Beijing Scitech-Mq Pharmaceuticals Limited

Phase 2 Recruiting
60 enrolled
EndocrineHead & Neck

Differentiated Thyroid Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡